Elena Rossi

Elena Rossi

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Dermatologic Surgery
Verified
Journal Article
Closed access
ERElena Rossi
Elena Rossi
FFFrancesca Farnetani
Francesca Farnetani
MTMyrto Trakatelli
Myrto Trakatelli
SCSilvana Ciardo
Silvana Ciardo
GPGiovanni Pellacani
Giovanni Pellacani
BACKGROUND: Plasma exeresis is an evolving technique for nonsurgical treatment of several skin conditions. Reflectance confocal microscopy (RCM) is a noninvasive tool that allows the “in vivo” imaging of the skin. OBJECTIVE: To evaluate the clinical improvement and collagen remodeling of the upper eyelid dermatochalasis after plasma exeresis. METHODS: Ten patients were subjected to 3 interventions of plasma exeresis. Photographic and RCM images were acquired at T0 (baseline) and T1 (4–6 weeks after final plasma exeresis). Eyelid dermatochalasis was rated as absent, mild, moderate, and severe according to the facial laxity rating scale, at clinical images at T0 and T1. An expert RCM evaluator classified collagen according to the predominant pattern of reticulated, coarse, huddled, or curled at T0 and T1. RESULTS: Clinical improvement of 2.6 ratings was observed at clinical evaluation. Collagen was classified as long straight fibers in all cases, according to RCM images. CONCLUSION: Plasma exeresis in this pilot study shows promising remodeling effects on the collagen of the upper eyelid, as viewed by RCM, and clinically improved appearance for the patient cohort, without any serious adverse events. This study suggests that plasma exeresis could be a valid solution for eyelid dermatochalasis, but further studies are required.

4 July 2011 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
LCLaura Cortesi
Laura Cortesi
ERElena Rossi
Elena Rossi
LCLara Della Casa
Lara Della Casa
ABAndrea Barchetti
Andrea Barchetti
ANAlessia Nicoli
Alessia Nicoli
AIAnna Iannone
Anna Iannone

10 July 2018 in Cephalalgia
Verified
Journal Article
Open access
PDF file
FAFabio Antonaci
Fabio Antonaci
ERElena Rossi
Elena Rossi
CVCristina Voiticovschi-Iosob
Cristina Voiticovschi-Iosob
GVGiorgio Dalla Volta
Giorgio Dalla Volta
SMSara Marceglia
Sara Marceglia
The use of frontal infrared thermography in the diagnosis of primary headaches provided scattering results due to measurement fluctuations and different types of headaches or research protocols. This study aims to assess the reliability of frontal infrared thermography in healthy individuals and provide a preliminary evaluation in chronic migraine patients using a commercial infrared thermal camera. Thermographic images were acquired in 20 controls and 15 patients at three consecutive time-points in two daily sessions. The Side Difference and Asymmetry Index parameters were defined. The reproducibility of the measurements, the correlation of Asymmetry Index and Side Difference with clinical evaluations and patient perceptions, and the ability of the parameters to discriminate between patients and controls were investigated. We reported a good reproducibility of the measurements (Inter-class Correlation Coefficient > 0.75 and Coefficient of Variation < 13.4%), independent from external factors. The Side Difference was significantly different between patients and controls ( p < 0.001). The Asymmetry Index showed good correlation with the side of unilateral pain ( p = 0.0056). Frontal infrared thermography can be used to quantify the difference between the right and the left side of frontal vascular changes in chronic migraine patients, provided that standardized conditions are satisfied.

6 February 2018 in Skin Research and Technology
Verified
Journal Article
Closed access
PDF file
ERElena Rossi
Elena Rossi
VMVictor Desmond Mandel
Victor Desmond Mandel
APAlessia Paganelli
Alessia Paganelli
FFFrancesca Farnetani
Francesca Farnetani
GPGiovanni Pellacani
Giovanni Pellacani

11 June 2020 in Dermatologic Therapy
Verified
Journal Article
Open access
PDF file
ERElena Rossi
Elena Rossi
CLC. Lasagni
C. Lasagni
MTM. Trakatelli
M. Trakatelli
SRS. Wertzberger Rowan
S. Wertzberger Rowan
CMC. Magnoni
C. Magnoni
We report the case of a positive COVID‐19 patient who presented to our hospital for a maculopapular skin rash which appeared 7 days after the onset of COVID‐19 symptoms. He was 34 years old and nothing relevant was recorded at his previous anamnesis. The patient was hospitalized for 3 days and received systemic therapy with steroid, antihistamines, tocilizumab, and hydroxicloroquine. On the third day of the hospitalization the cutaneous rash had almost completely disappeared.

26 May 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
ERElena Rossi
Elena Rossi
MTMyrto Trakatelli
Myrto Trakatelli
LGLuca Giacomelli
Luca Giacomelli
BFBarbara Ferrari
Barbara Ferrari
MFMariangela Francomano
Mariangela Francomano
CMCristina Magnoni
Cristina Magnoni